Masimo Corporation (MASI)
$179.95+0.00%Close
BUYBULL · day 82
Key stats
- Market cap
- $9.4B
- Beta
- 1.18
- P/E (TTM)
- 124.97
- 1W
- +0.63%
- 1M
- +0.86%
- vs SPY 1W
- -0.53%
- vs SPY 1M
- -2.13%
Industry peers
FMP comparable companies · ranked by market cap
- BAXSELLBaxter International Inc.$12.5BRECOVERYQ 3$24.22+1.88%
- RGENSELLRepligen Corporation$10.7BBEARQ 26$189.50+6.13%
- AVTRBUYAvantor, Inc.$10.7BBULLQ 4$15.81+1.82%
- BIOSELLBio-Rad Laboratories, Inc.$10.2BBULLQ 19$379.82+1.60%
- MOHSELLMolina Healthcare, Inc.$10.1BRECOVERYQ 10$194.05+0.60%
- HSICSELLHenry Schein, Inc.$9.6BBEARQ 14$84.23-0.73%
- ATRSELLAptarGroup, Inc.$7.7BBEARQ 17$120.61-1.17%
- ABVXSELLAbivax S.A.$6.7BCRISISQ 57$91.73-1.01%
- RYTMSELLRhythm Pharmaceuticals, Inc.$6.3BBEARQ 20$92.45+1.27%
- STVNSELLStevanato Group S.p.A.$5.5BBEARQ 7$20.05+0.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on MASI?
- LOPJLB’s latest quantitative signal on Masimo Corporation (MASI) is BUY in a BULL regime. Signals are updated daily.
- What market regime is MASI in?
- Masimo Corporation (MASI) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Masimo Corporation (MASI) do?
- Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET p…